Glioma Therapy: A Novel Insight in the Immunotherapeutic Regime with T11TS/SLFA-3

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|6|4|245-270

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.6, Iss.4, 2006-12, pp. : 245-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

T11TS/SLFA-3 Differentially Regulate the Population of Microglia and Brain Infiltrating Lymphocytes to Reduce Glioma by Modulating Intrinsic Bcl-2 Expression rather than p53

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 2, 2007-06 ,pp. : 145-155

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance

By  

Current Molecular Pharmacology, Vol. 3, Iss. 1, 2010-01 ,pp. : 37-52

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy and Targeted Toxins for Glioma

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 535-557

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia Helps Glioma to Fight Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-01 ,pp. : 381-390

Bentham Science Publishers

Access to resources Recommend Favorite

Exploiting Metabolic Differences in Glioma Therapy

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 4, 2012-12 ,pp. : 280-293

Bentham Science Publishers

Access to resources Recommend Favorite